Purification of Human Serum Paraoxonase-1

被引:0
|
作者
Naik, R. Redya [1 ]
Sankarshana, T. [1 ]
机构
[1] Osmania Univ, Dept Pharm, Univ Coll Technol, Hyderabad 500007, Andhra Pradesh, India
关键词
Paraoxonase; purification; human serum;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Membrane proteins play key roles in fundamental biological processes, such as transport of molecules, signalling, energy utilization, and maintenance of cell and tissue structures. Serum paraoxonase (PON1, EC 3.1.8.1.) is a protein of 354 amino acids with a molecular mass of 43 kDa is a high density lipid (HDL) associated, calcium-dependent enzyme whose 3D structure, active site residues and physiological substrates are not known. It is highly conserved in mammals but is absent in fish, birds, and invertebrates, such as arthropods. Purification of PON1 has been challenging for a long time. Here, we report a novel purification technique for this enzyme, which allowed us to obtain human serum paraoxonase 1 (hPON1) using straightforward chromatographic methods. The PON1-specific inhibitor 2-hydroxyquinoline almost completely inhibited paraoxonase and lactonase activities, while only moderately inhibiting arylesterase activity. By this method the purity of the isolated PON-1 was increased many folds. Later the purified sample was assessed for its paraoxonase, lactonase and arylesterase activities.
引用
收藏
页码:80 / 85
页数:6
相关论文
共 50 条
  • [31] Quantification of the arylesterase activity of paraoxonase-1 in human blood
    Dias, Clara G.
    Batuca, Joana R.
    Marinho, Aline T.
    Caixas, Umbelina
    Monteiro, Emilia C.
    Antunes, Alexandra M. M.
    Pereira, Sofia A.
    [J]. ANALYTICAL METHODS, 2014, 6 (01) : 289 - 294
  • [32] Purification of Human Serum Paraoxonase 1 and Investigation of Its Kinetic Properties
    Bayrak, A.
    Bayrak, T.
    Demirpence, E.
    Kilinc, K.
    [J]. FEBS JOURNAL, 2009, 276 : 135 - 135
  • [33] Relationship of human paraoxonase-1 serum activity and genotype with atherosclerosis in individuals from the Deep South
    Coombes, R. Hunter
    Crow, J. Allen
    Dail, Mary Beth
    Chambers, Howard W.
    Wills, Robert W.
    Bertolet, Barry D.
    Chambers, Janice E.
    [J]. PHARMACOGENETICS AND GENOMICS, 2011, 21 (12): : 867 - 875
  • [34] Impact of antibacterial drugs on human serum paraoxonase-1(hPON1)activity:an in vitro study
    Hakan Syt
    Elif Duygu Kaya
    Skr Beydemir
    [J]. Asian Pacific Journal of Tropical Biomedicine, 2014, (08) : 603 - 609
  • [35] Purification of human serum paraoxonase and effect of acetylsalicylic acid on paraoxonase activity
    Demir, Nazan
    Nadaroglu, Hayrunnisa
    Demir, Yasar
    [J]. PHARMACEUTICAL BIOLOGY, 2008, 46 (06) : 393 - 399
  • [36] Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis
    Zinellu, Angelo
    Sedda, Stefania
    Mangoni, Arduino A.
    [J]. ANTIOXIDANTS, 2023, 12 (08)
  • [37] Paraoxonase-1 and cardiovascular disease
    Mackness, B.
    Mackness, M. L.
    [J]. PARAOXNASES: THEIR ROLE IN DISEASE DEVELOPMENT AND XENOBIOTIC METABOLISM, 2008, 6 : 51 - 60
  • [38] Targeting paraoxonase-1 in atherosclerosis
    Mackness, Mike
    Mackness, Bharti
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (07) : 829 - 837
  • [39] Solubilization and Humanization of Paraoxonase-1
    Sarkar, Mohosin
    Harsch, Christina Keventzidis
    Matic, George T.
    Hoffman, Kathryn
    Norris, Joseph R., III
    Otto, Tamara C.
    Lenz, David E.
    Cerasoli, Douglas M.
    Magliery, Thomas J.
    [J]. JOURNAL OF LIPIDS, 2012, 2012
  • [40] Misunderstandings about paraoxonase-1
    Mackness, Michael
    Sozmen, Eser Y.
    [J]. BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2022, 88 (01)